612 related articles for article (PubMed ID: 19487957)
21. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
22. Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase.
Moreno Y Banuls L; Katz A; Miklos W; Cimmino A; Tal DM; Ainbinder E; Zehl M; Urban E; Evidente A; Kopp B; Berger W; Feron O; Karlish S; Kiss R
Mol Cancer; 2013 Apr; 12():33. PubMed ID: 23621895
[TBL] [Abstract][Full Text] [Related]
23. [New aspects on the mode of action of cardiac glycosides].
Fricke U
Fortschr Med; 1976 Nov; 94(32):1037-45. PubMed ID: 136410
[TBL] [Abstract][Full Text] [Related]
24. New molecular determinants controlling the accessibility of ouabain to its binding site in human Na,K-ATPase alpha isoforms.
Crambert G; Schaer D; Roy S; Geering K
Mol Pharmacol; 2004 Feb; 65(2):335-41. PubMed ID: 14742675
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic properties of human Na,K-ATPase alpha1beta3 isozyme.
Yu C; Xie Z; Askari A; Modyanov NN
Arch Biochem Biophys; 1997 Sep; 345(1):143-9. PubMed ID: 9281321
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
Ozaki H; Nagase H; Urakawa N
J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
[TBL] [Abstract][Full Text] [Related]
27. Determinants of human and mouse melanoma cell sensitivities to oleandrin.
Lin Y; Dubinsky WP; Ho DH; Felix E; Newman RA
J Exp Ther Oncol; 2008; 7(3):195-205. PubMed ID: 19066128
[TBL] [Abstract][Full Text] [Related]
28. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
Haustein KO; Graumann G; Stephan B
Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
[TBL] [Abstract][Full Text] [Related]
29. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
30. Selective Assembly of Na,K-ATPase α2β2 Heterodimers in the Heart: DISTINCT FUNCTIONAL PROPERTIES AND ISOFORM-SELECTIVE INHIBITORS.
Habeck M; Tokhtaeva E; Nadav Y; Ben Zeev E; Ferris SP; Kaufman RJ; Bab-Dinitz E; Kaplan JH; Dada LA; Farfel Z; Tal DM; Katz A; Sachs G; Vagin O; Karlish SJ
J Biol Chem; 2016 Oct; 291(44):23159-23174. PubMed ID: 27624940
[TBL] [Abstract][Full Text] [Related]
31. Molecular and cellular level of action of digitalis.
Charlemagne D
Herz; 1993 Apr; 18(2):79-85. PubMed ID: 7684015
[TBL] [Abstract][Full Text] [Related]
32. Defective activity and isoform of the Na,K-ATPase in the dilated cardiomyopathic hamster.
Paganelli F; Mougenot R; Maixentt JM
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):255-60. PubMed ID: 11354998
[TBL] [Abstract][Full Text] [Related]
33. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
Hauck C; Frishman WH
Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
[TBL] [Abstract][Full Text] [Related]
34. The effect of digitalis glycosides-specific antisera on the binding of the glycosides to (Na+ + K+)-ATPase.
Bossaller C
Arzneimittelforschung; 1981; 31(4):625-8. PubMed ID: 6264929
[TBL] [Abstract][Full Text] [Related]
35. Cardiac glycosides regulate endothelial tissue factor expression in culture.
Stähli BE; Breitenstein A; Akhmedov A; Camici GG; Shojaati K; Bogdanov N; Steffel J; Ringli D; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2769-76. PubMed ID: 18029910
[TBL] [Abstract][Full Text] [Related]
36. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
Schoner W; Scheiner-Bobis G
Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
[TBL] [Abstract][Full Text] [Related]
37. Class I antiarrhythmic drug effects on ouabain binding to guinea pig cardiac Na+ -K+ ATPase.
Almotrefi AA; Basco C; Moorji A; Dzimiri N
Can J Physiol Pharmacol; 1999 Nov; 77(11):866-70. PubMed ID: 10593659
[TBL] [Abstract][Full Text] [Related]
38. Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke.
Tzen JT; Jinn TR; Chen YC; Li FY; Cheng FC; Shi LS; She HKh; Chen BC; Hsieh V; Tu ML
Acta Pharmacol Sin; 2007 May; 28(5):609-15. PubMed ID: 17439716
[TBL] [Abstract][Full Text] [Related]
39. [Age-dependent regulation of cardiac glycoside receptors].
Erdmann E; Brown L; Lorenz B; Kreuzer E; Kemkes B; Weinhold C; Holper K; Klövekorn W
Z Kardiol; 1985; 74 Suppl 7():33-8. PubMed ID: 3004053
[TBL] [Abstract][Full Text] [Related]
40. Functional evidence in diseased human heart fibers for multiple sensitivities of the inotropic ouabain receptor Na+,K+-ATPase (NKA).
Grupp G; Grupp IL; Melvin DB; Schwartz A
Prog Clin Biol Res; 1988; 258():215-22. PubMed ID: 2837772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
